Recent Updates
Recently added Catalysts

Oscar Health, Inc.

OSCRFDA catalysts, PDUFA dates & pipeline intelligence
$24.73
▼ -1.44 · -5.5%

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full OSCR financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $10.6952W HIGH $38.50
Volume
6.61 M
Value Traded
166.80 M
Short % Float
6.61%
Days to Cover
3.9
-20.35%Week
-26.07%1 Month
-22.82%3 Month
+9.23%6 Month
+89.79%1 Year
+141.27%5 Year

Cash Data

Unlock OSCR cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
7.68 B
EPS (TTM)
2.88
P/E Ratio
8.59
Ent. Value
-814.82 M
Total Shares
310.69 M
Float Shares
253.30 M
Insiders
17.93%
Institutions
67.42%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every OSCR catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

OSCR Catalyst Timeline

Dated clinical, regulatory and corporate events for Oscar Health, Inc.

Catalyst Timeline

Dated clinical, regulatory & corporate events for Oscar Health, Inc.

1Total events
0Upcoming
0Tier-1 (high impact)
2026 to 2026Coverage

Event history 1

●Quarterly UpdateCorporate
Q2 2026 financial results release
Unlock the full OSCR catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How OSCR actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all OSCR historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Oscar Health, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every OSCR program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every OSCR trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock OSCR insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
WITTMAN VANESSA AMESDirectorSell -25,000 112,121 held$32.24 09/18/2026
Unlock the full OSCR insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
PFM HEALTH SCIENCES, LP 1.5 % (15.4 %) 15.41 M 499.84 K -3.7% ( -19.18 K)
Unlock every fund holding OSCR
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in OSCR
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see OSCR ownership
Insider and institutional ownership, quarter by quarter.

OSCR Short Interest

Shares sold short, counted twice a month.

6.61%
Short % of Float
of tradable shares sold short
16.7M
Shares Sold Short
-8.5% vs prior count
3.9 Moderate
Days to Cover
trading days of normal volume to buy every short share back
4.3M
Avg Daily Volume
the average used for days to cover
Unlock OSCR short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
2026-11-27
Unlock OSCR option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live OSCR option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock OSCR options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How OSCR ranks across every disease it competes in

Competitive Position is a premium feature
See how OSCR ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

OSCR News

-OSCR
Nov 18, 2026
OSCRGeneral
▼ -5.1%on this news

Hy-Vee Health with Oscar Expands Across Iowa, Into Kansas City and Omaha for 2027 Open Enrollment

Hy-Vee Health with Oscar is expanding its services across Iowa and into Kansas City and Omaha for the 2027 Open Enrollment period. Starting November 1, 2026, individuals can enroll through HealthCare.gov, benefiting from affordable healthcare options, including $0 primary care visits. The plan offers access to numerous healthcare providers and a rewards program for members.

Read more →
-OSCR
Nov 17, 2026
OSCRGeneral
▼ -7.6%on this newsshared move

Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment

Oscar Health announced new health plans for Florida residents for the 2027 Open Enrollment. The RetireEase plan aims to support early retirees with affordable coverage options. Additional offerings include personalized health plans and partnerships with major healthcare providers, enhancing access to care. Enrollment begins on November 1, 2026.

Read more →
-OSCR
Nov 17, 2026
OSCRGeneral
▼ -7.6%on this newsshared move

Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment

Oscar Health announced new health plan options for Texas individuals and families for the 2027 Open Enrollment. The new RetireEase plan targets early retirees, offering affordable healthcare solutions. Additional features include support for Spanish-speaking members and partnerships for supplemental coverage. Open Enrollment begins on November 1, 2026, with coverage starting January 1, 2027.

Read more →
-OSCR
Nov 16, 2026
OSCRGeneral

Oscar Health Expands its Board of Directors with Technology, Healthcare and Product Innovators to Advance Consumer Healthcare

Oscar Health announced the addition of Tomer Cohen, Eric Larsen, and Rajat Taneja to its Board of Directors, effective November 13, 2026. These appointments aim to enhance Oscar's consumer healthcare offerings and technology platforms. CEO Mark Bertolini emphasized their commitment to innovation and improving the healthcare experience for consumers.

Read more →
-OSCR
Nov 10, 2026
OSCRGeneral

Oscar Grows Across Ohio to Serve Nearly the Entire State for 2027 Open Enrollment

Oscar Health announced its expansion across Ohio, now serving 73 of 88 counties for the 2027 Open Enrollment. The insurer is entering 33 new counties, including Akron and Toledo, to provide affordable health plans. Oscar's offerings include various coverage options and tailored plans for different life stages, enhancing accessibility for residents.

Read more →
-OSCR
Nov 5, 2026
OSCRGeneral
▼ -5.7%on this newsshared move

Oscar Health Announces Financial Results for Third Quarter 2026 and Raises Full Year 2026 Outlook

Oscar Health reported its third quarter 2026 financial results, showing total revenue of approximately $5.1 billion, up from $3.0 billion in Q3 2025. The company raised its full-year revenue outlook to between $19.0 billion and $19.3 billion. CEO Mark Bertolini emphasized Oscar's growth strategy and strong market positioning. The medical loss ratio improved to 84.0%, reflecting better pricing strategies.

Read more →
-OSCR
Oct 20, 2026
OSCRGeneral

Oscar Introduces a New Wave of Consumer Health Products

Oscar Health, Inc. has launched its 2027 health insurance lineup, expanding to 713 counties across 21 states. The new offerings include RetireEase, a plan for early retirees transitioning to Medicare, and a range of health plans that provide significant savings. Oscar also introduces supplemental options and rewards for healthy actions.

Read more →
-OSCR
Oct 12, 2026
OSCRConferences/Events

Oscar Health, Inc. 2026 Third Quarter Earnings Conference Call

Oscar Health, Inc. will announce its third quarter 2026 financial results on November 5, 2026. Management will hold a conference call at 8:00 AM (ET) to discuss these results. A live audio webcast will be accessible, and a replay will be available for 90 days afterward.

Read more →
-OSCR
Sep 19, 2026
OSCRGeneral

Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners

Oscar Health announced that Thrive Capital distributed approximately 6.3 million Class A shares to its limited partners on September 18, 2026. This distribution marks a return of capital after a 14-year holding period. Joshua Kushner, founder of Thrive Capital, reaffirmed his commitment to Oscar Health's long-term growth and has no plans to sell his shares.

Read more →
-OSCR
Aug 6, 2026
OSCRGeneral
▼ -11.9%on this news

Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook

Oscar Health, Inc. reported record financial results for the first half of 2026, with total revenue reaching approximately $9.5 billion, a significant increase from $5.9 billion in the previous year. The company also improved its medical loss ratio to 75.0% and raised its full-year guidance, reflecting strong operational performance. CEO Mark Bertolini emphasized the company's strategic positioning for long-term growth.

Read more →
-OSCR
Jul 28, 2026
OSCRConferences/Events
▲ +10.8%on this news

Oscar Health, Inc. to Host 2026 Investor Day

Oscar Health, Inc. will hold its 2026 Investor Day on September 16, 2026. The event will feature discussions on the company's corporate strategy and long-term financial targets. A live webcast will be available, and the presentation will be archived for 90 days on the investor relations website.

Read more →
-OSCR
Jul 13, 2026
OSCRConferences/Events

Oscar Health, Inc. 2026 Second Quarter Earnings Conference Call

Oscar Health, Inc. will announce its second quarter 2026 financial results on August 6, 2026. A conference call will follow at 8:00 AM (ET) to discuss these results. The call will be archived for 90 days on the company's investor relations website.

Read more →
-OSCR
May 6, 2026
OSCRGeneral
▲ +10.6%on this news· ran to +23% by day 3

Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance

Oscar Health reported Q1 2026 revenue of $4.6 billion, up from $3.0 billion in the prior year. Net income reached $679 million, driven by higher membership and disciplined pricing. The medical loss ratio improved to 70.5% from 75.4%. The company reaffirmed its full-year 2026 guidance.

Read more →
-OSCR
Apr 21, 2026
OSCRGeneral

Oscar Health, Inc. Appoints Director Siddhartha Sankaran as Independent Chair of the Board

Oscar Health, Inc. appointed Siddhartha Sankaran as the new Chair of the Board, effective June 4, 2026. He succeeds Jeffery Boyd, who has served since February 2021. Sankaran brings over 20 years of experience in the insurance industry and is expected to guide Oscar through its next growth phase.

Read more →
-OSCR
Apr 20, 2026
OSCRGeneral

Meet Lucie. A New Way to Shop for Healthcare.

The article introduces a new healthcare shopping platform named Lucie. It emphasizes the platform's focus on privacy and protection for users. However, specific details about its features or benefits are not provided.

Read more →
-OSCR
Apr 7, 2026
OSCRConferences/Events

Oscar Health, Inc. 2026 First Quarter Earnings Conference Call

Oscar Health, Inc. will announce its first quarter 2026 financial results on May 6, 2026. A conference call will follow at 8:00 AM (ET) to discuss these results. The call will also be archived for 90 days on Oscar's investor relations website. Oscar serves around 3.4 million members.

Read more →
-OSCR
Jan 13, 2026
OSCRConferences/Events

Oscar Health, Inc. 2025 Fourth Quarter and Full Year Earnings Conference Call

Oscar Health, Inc. will announce its fourth quarter and full year 2025 financial results on February 10, 2026. A conference call will follow at 8:00 AM ET to discuss these results. The call will be archived for 90 days on the company's investor relations website. Oscar Health continues to focus on technology-driven healthcare solutions.

Read more →
-OSCR
Sep 16, 2025
OSCRGeneral

Oscar Health Prices Upsized

Oscar Health, Inc. has priced its upsized offering of $355 million in convertible senior subordinated notes, intended to bolster long-term growth and market adoption. The offering's net proceeds, estimated at approximately $342.5 million, will be used for corporate purposes and strategic initiatives. Notably, Oscar aims to enhance consumer healthcare experiences while pursuing opportunities related to premium tax credits.

Read more →
-OSCR
Sep 15, 2025
OSCRGeneral

Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

Oscar Health, Inc. has announced a proposed offering of $350 million in convertible senior subordinated notes, intending to use the proceeds for general corporate purposes and strategic growth initiatives. This initiative aims to enhance consumer healthcare experiences through advancements in AI and potentially extend premium tax credits. The company also plans to settle conversions with cash or shares of its common stock. The notes will be unsecured and subject to various conditions that could affect their performance and the company’s stock price.

Read more →
-OSCR
Nov 20, 2023
OSCRGeneral
▲ +8.8%on this news

Oscar Health, Inc. ir.hioscar.com News Release Oscar Health, Inc. Announces that Mark Bertolini s Foundation and Deerfield Management have Entered into an Agreement with a Selling Shareholder to Purchase Shares of Oscar

Oscar Health, Inc. announced a Stock Purchase Agreement where Deerfield Management and the Anahata Foundation will purchase shares of its Common Stock. Deerfield is to acquire 3 million shares while Anahata will buy 2 million shares. The transactions are scheduled to close around November 22, 2023, pending customary conditions. Oscar is not a party to these agreements but benefits from the endorsement and financial backing of these investors.

Read more →

About Oscar Health, Inc.

New York, NY 2,305 employees hioscar.com
Headquarters75 VARICK STREET, NEW YORK, NY, 10013
BIOPHARMAWATCH ELITE
Trade the next OSCR catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime